• Sonuç bulunamadı

Miscellaneous attractive studies

N/A
N/A
Protected

Academic year: 2021

Share "Miscellaneous attractive studies"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Address for Correspondence: Prof. Dr. Çetin Erol, Ankara Üniversitesi Tıp Fakültesi, İbn-i Sina Hastanesi, Kardiyoloji Anabilim Dalı, Ankara-Türkiye

Phone: +90 312 310 33 33 /27 79 E-mail: ctnerol@yahoo.com

©Copyright 2021 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com DOI:10.5152/AnatolJCardiol.2021.7

Editorial

461

Miscellaneous attractive studies

Akgün et al. from Turkey investigated the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Turkish octogenarians with non-valvular atrial fibrillation in a real-world tertiary center setting. The results will encourage physicians to use NOACs in this elderly group.

Uslu et al. from Turkey observed a significant and consistent increase in all electrocardiographic parameters studied in the acute phase after cryoballoon ablation for atrial fibrillation. This study may have important clinical implications.

The clinical features, treatment options, and clinical outcomes of patients with hypertrophic cardiomyopathy (HCM) and uncommon severe right ventricular hypertrophy were evaluated by Dong et al. from China. The study suggests that the right side of the heart in patients with HCM should receive more attention from clinicians.

Does left atrial expansion index affect recurrent strokes? Shih Hung Hsiao from Taiwan presents his findings about this important issue.

Novel method and results are described in the study “Clinical analysis of cardiac autonomic ganglion plexus ablation for bradyarrhythmia” conducted by Shao et al. from China.

Hacıhamdioğlu et al. from Turkey investigated arterial stiffness as a target organ damage test in childhood hypertension. You will be happy to see the results.

Görmel et al. from Turkey aimed to assess the efficacy of Carillon Mitral Contour System in patients with “inoperable” severe functional mitral regurgitation. I hope the data will add to the literature of this topic.

In addition, the issue contains interesting case reports, letters, and e-page originals. I hope this new issue will be of interest to our readers.

Prof. Dr. Çetin Erol Editor-in-Chief Ankara-Turkey

Referanslar

Benzer Belgeler

I am also very happy to offer another very valuable review, “Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation,” by Anetta Undas

Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, are approved for treatment of stroke prevention in patients with nonvalvular atrial

An analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibitor Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial

Objective: This study aimed to evaluate whether fluvastatin therapy could decrease the probability of atrial fibrillation (AF) progression from paroxysmal AF to permanent AF

Objective: This study aimed to determine the differences in terms of demographic characteristics and preferred stroke prevention strategies for patients with non-valvular

Therefore, monitoring the anticoagulant effects of NOAC is important in this subset of an- ticoagulated patients; the need for anticoagulation at high body weights is considered

In their study, the authors re- ported that warfarin-treated patients had higher levels of self- reported symptoms of depression and anxiety and compromised health-related quality

I have read with great interest the article entitled “Compari- son of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular